Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Single-Payer Healthcare
  • Federal Workers’ Medical Records
  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus

WHAT'S NEW

  • Single-Payer Healthcare
  • Federal Workers' Medical Records
  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jul 18 2024

Full Issue

Scientist's MRIs Highlight Psilocybin Boosting Brain Plasticity

NPR reports on fascinating research that shows how taking the psychedelic drug psilocybin changes brain process, producing mind-altering effects and temporary boosts to the brain's ability to adapt and change. In other research news, CBD may protect skin from the sun.

NPR: This Is Your Brain On Drugs: How Psilocybin Can Trigger Plasticity

In the name of science, Dr. Nico Dosenbach had scanned his own brain dozens of times. But this was the first time he'd taken a mind-bending substance before sliding into the MRI tunnel. "I was, like, drifting deeper into weirdness," he recalls. "I didn't know where I was at all. Time stopped, and I was everyone." Dosenbach, an associate professor of neurology at Washington University School of Medicine in St. Louis, had been given a high dose of psilocybin, the active substance in magic mushrooms, by his colleagues. (Hamilton, 7/18)

Axios: CBD May Help Protect Skin From Sun Damage: Study

An active ingredient in marijuana could help shield skin from sun damage, according to new research in the Journal of the American Academy of Dermatology. (Goldman, 7/17)

Also —

NPR: The Pros And Cons Of Mammograms Should Be Explained To Women, Study Says

New research makes the case for educating women in their 40s — who've been caught in the crossfire of a decades-long debate about whether to be screened for breast cancer with mammograms — about the harms as well as the benefits of the exam. After a nationally representative sample of U.S. women between the ages of 39 and 49 learned about the pros and cons of mammography, more than twice as many elected to wait until they turn 50 to get screened, a study released Monday in the Annals of Internal Medicine found. (Cohen, 7/17)

CNN: Women With Endometriosis Face Fourfold Higher Risk Of Ovarian Cancer, Study Suggests 

The risk of developing ovarian cancer appears to jump about fourfold among women with endometriosis, compared with women who haven’t been diagnosed with the condition, a new study finds. (Howard, 7/17)

Stat: Bone Marrow Donors Needn’t Be Perfect Match In Cancer Care: Study

As a hematologist-oncologist in Miami, Mikkael Sekeres always hopes his patients will find a perfect match for the bone marrow transplant they need to save their lives — but he doesn’t expect it. Most of his patients are Latino or African American, and rates of perfect matches are much lower for racial or ethnic minorities. That gloomy picture could soon change. (Chen, 7/17)

The New York Times: Moving In Childhood Contributes To Depression, Study Finds

Researchers who conducted a large study of adults in Denmark, published on Wednesday in the journal JAMA Psychiatry, found something they had not expected: Adults who moved frequently in childhood have significantly more risk of suffering from depression than their counterparts who stayed put in a community. In fact, the risk of moving frequently in childhood was significantly greater than the risk of living in a poor neighborhood, said Clive Sabel, a professor at the University of Plymouth and the paper’s lead author. (Barry, 7/17)

Axios: Medical Debt Fuels Mental Health Treatment Gap

As many as 1 in 4 U.S. adults with depression and anxiety can't pay their medical bills — a situation that could be limiting their ability to get timely psychiatric care, Johns Hopkins researchers found. (Bettelheim, 7/18)

Stat: 'Too Early To Say' When Novartis Will File Myelofibrosis Drug

A Novartis executive on Thursday said “it’s too early to say” whether the company would still submit an experimental myelofibrosis drug for regulatory approval this year, amid questions about the medicine’s data profile and whether it’s sufficient for filing. (Joseph, 7/18)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 8
  • Thursday, May 7
  • Wednesday, May 6
  • Tuesday, May 5
  • Monday, May 4
  • Friday, May 1
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF